Survival from Uveal Melanoma in England and Wales 1986 to 2001

REFERENCES

• Stang A, Parkin D M, Ferlay J, et al. International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification. Int J Cancer 2005; 114(1)114–123
   PubMed Web of Science ®Google Scholar
• Singh A D, Shields C L, Shields J A. Prognostic factors in uveal melanoma. Melanoma Res. 2001; 11(3)255–263
   PubMed Web of Science ®Google Scholar
• Brandberg Y, Kock E, Oskar K, Trampe E, Seregard S. Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study. Eye 2000; 14(6)839–846
   PubMedGoogle Scholar
• Bergman L, Seregard S, Nilsson B, Lundell G, Ringborg U, Ragnarsson-Olding B. Uveal melanoma survival in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci. 2003; 44: 3282–3287
   PubMed Web of Science ®Google Scholar
• Mooy C M, De Jong P T. Prognostic parameters in uveal melanoma. Surv Ophthalmol. 1996; 41(3)215–228
   PubMed Web of Science ®Google Scholar
• Singh A D, Damato B, Howard P, et al. Uveal melanoma: Genetic aspects. Ophthalmol Clin North Am 2005; 18(1)85–97
   PubMedGoogle Scholar
• Bergman L, Nilsson B, Lundell G, et al. Ruthenium brachytherapy for uveal melanoma, 1979–2003: Survival and functional outcomes in the Swedish population. Ophthalmology. 2005; 112(5)834–840
   PubMed Web of Science ®Google Scholar
• Singh A D, Topham A. Survival rates with uveal melanoma in the United States: 1973–1997. Ophthalmology. 2003; 110: 962–965
   PubMed Web of Science ®Google Scholar
• Diener-West M, Earle J D, Fine S L, Hawkins B S, Moy C S, Reynolds S M, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. III Initial mortality findings. COMS Report No. 18. Arch Ophthalmol. 2001; 119: 969–982
   PubMedGoogle Scholar
• Department of Health. National Specialist Commissioning Advisory Group, http://www.dh.gov.uk/ accesses December 2004
   Google Scholar
• Sikora K. Cancer survival in Britain is poorer than that of her comparable European neighbours. BMJ 1999; 319(7208)461–462
   PubMedGoogle Scholar
• World Health Organisation. International Classification of Diseases for Oncology (ICD-O), 2nd ed. WHO, Geneva 1990
   Google Scholar
• World Health Organisation. International Classification of Diseases, 1975, 9th revision. WHO, Geneva 1977
   Google Scholar
• World Health Organisation. International Statistical Classification of Diseases and Related Health Problems, 1989, 10th revision. WHO, Geneva 1992
   Google Scholar
• Carstairs V. Deprivation indices: their interpretation and use in relation to health. J Epidemiol Community Health. 1995; 4(9)S3–S8
   Google Scholar
• Department of Environment Transport and the Regions. Measuring multiple deprivation at the small area level: the indices of deprivation. DETR, London 2000
   Google Scholar
• National Assembly for Wales. Welsh Index of Multiple Deprivation. National Assembly for Wales, Cardiff 2000
   Google Scholar
• Office for National Statistics. 1991 Census: small area statistics and local base statistics. 1991, Report No. 1
   Google Scholar
• Penhale B, Noble M. Ward level population estimates mid-1998. Social Disadvantage Research Group, Department of Policy and Social Work, University of Oxford, Oxford 2000
   Google Scholar
• Office for National Statistics. Census 2001 homepage, www.statistics.gov.uk/census2001/ accessed 20 December 2004
   Google Scholar
• Woods L M, Rachet B, Riga M, Stone N, Shah A, Coleman M P. Geographical variation in life expectancy at birth in England and Wales is largely explained by deprivation. J Epidemiol Community Health. 2005; 59: 115–120
   PubMed Web of Science ®Google Scholar
• Berkson J, Gage R P. Calculation of survival rates for cancer. Proc Staff Meet Mayo Clinic 1950; 25: 270–286
   PubMed Web of Science ®Google Scholar
• Esteve J, Benhamou E, Croasdale M, Raymond L. Relative survival and the estimation of net survival: elements for further discussion. Stat Med. 1990; 9: 529–538
   PubMed Web of Science ®Google Scholar
• Dickman P W, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004; 23: 51–64
   PubMed Web of Science ®Google Scholar
• StataCorp. STATA statistical software [7.0]. STATA Corporation, College Station, TX 1997
   Google Scholar
• Sant M, Allemani C, Berrino F, Coleman M P, Aareleid T, Chaplain G, et al. Breast carcinoma survival in Europe and the USA: a population-based study. Cancer 2004; 100: 715–722
   PubMed Web of Science ®Google Scholar
• Gatta G, Ciccolallo L, Capocaccia R, Coleman M P, Hakulinen T, Møller H, et al. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer 2003; 39: 2214–2222
   PubMed Web of Science ®Google Scholar
• Gatta G, Capocaccia R, Coleman M P, Gloeckler Ries L A, Berrino F. Childhood cancer survival in Europe and the United States. Cancer 2002; 95: 1767–1772
   PubMed Web of Science ®Google Scholar
• Gatta G, Capocaccia R, Coleman M P, Ries L AG, Hakulinen T, Micheli A, et al. Toward a comparison of survival in American and European cancer patients. Cancer 2000; 89: 893–90031
   PubMed Web of Science ®Google Scholar
• Coleman M P, Babb P, Damiecki P, Grosclaude P, Honjo S, Jones J, et al. Cancer survival trends in England and Wales, 1971-1995: deprivation and NHS Region. The Stationary Office, London 1999; 449–456
   Google Scholar
• Finger P T. Do you speak ocular tumor?. Ophthalmology 2003; 110: 13–4
   PubMed Web of Science ®Google Scholar
• Brenner H, Arndt V. Recent increase in cancer survival according to age: higher survival in all age groups, but widening age gradient. Cancer Causes Control Nov, 2004; 15(9)903–910
   PubMed Web of Science ®Google Scholar
• Damato B. Detection of uveal melanoma by optometrists in the United Kingdom. Ophthalmic Physiol Opt. 2001; 21: 268–271
   PubMed Web of Science ®Google Scholar
• Ah-Fat F G, Damato B E. Delays in the diagnosis of uveal melanoma and effect on treatment. Eye 1998; 12: 781–782, (pt5)
   PubMed Web of Science ®Google Scholar
• Diener-West M, Hawkins B S, Markowitz J A, Schachat A P. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol. 1992; 110: 245–250
   PubMed Web of Science ®Google Scholar
• Seregard S. Long-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1,066 patients. Acta Ophthalmol Scand. 1999; 77: 414–417
   PubMedGoogle Scholar
• Kroll S, Char D H, Quivey J, Castro J. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma. Ophthalmology 1998; 105: 2035–2045
   PubMed Web of Science ®Google Scholar
• Damato B, Lecuona K. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology 2004; 111: 977–983
   PubMed Web of Science ®Google Scholar
• Hungerford J L. Current trends in the treatment of ocular melanoma by radiotherapy. Clin Exp Ophthal. 2003; 31: 8–13
   PubMed Web of Science ®Google Scholar
• Zimmerman L E, McLean I W. An evaluation of enucleation in the management of uveal melanomas. Am J Ophthalmol. 1979; 87(6)741–760
   PubMedGoogle Scholar
• Singh A D, Rennie I G, Kivela T, et al. The Zimmerman-McLean-Foster hypothesis: 25 years later. Br J Ophthalmol. 2004; 88(7)962–967
   PubMed Web of Science ®Google Scholar
• Eskelin S, Pyrhonen S, Summanen P, et al. Tumor doubling times in metastatic malignant melanoma of the uvea: Tumor progression before and after treatment. Ophthalmology 2000; 107(8)1443–1449
   PubMed Web of Science ®Google Scholar
• Woods L M, Rachet B, Coleman M P. Choice of geographic unit influences socioeconomic inequalities in breast cancer survival. Br J Cancer. 2005; 92: 1279–1282
   PubMed Web of Science ®Google Scholar
• Fraser S, Bunce C, Wormald R, Brunner E. Deprivation and late presentation of glaucoma: case-control study. Br Med J. 1998; 322(7287)639–643
   Google Scholar
• Bullard J, Coleman M P, Robinson D, Luk J M, Bell J, Peto J. Completeness of cancer registration: a new method for routine use. Br J Cancer. 2000; 82: 1111–1116
   PubMed Web of Science ®Google Scholar